GlassScriptPhysician profile
Amy J Armstrong
NPI 1568606523
$4,746.70
in general payments reported to CMS, 2019-2025
17 companies · $877 in 2025
The $877 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2021: $64.37 · 2022: $154 · 2023: $1,664 · 2024: $1,813 · 2025: $877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,200 · Food and Beverage: $583 · Education: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,200.00 |
| Food and Beverage | $583.18 |
| Education | $570.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,200.00 | 2023-2024 | Jemperli |
| Intuitive Surgical, INC. | $570.88 | 2025 | |
| Medtronic Vascular, INC. | $173.72 | 2019 | |
| Alexion Pharmaceuticals, INC. | $143.84 | 2024-2025 | Koselugo |
| Novartis Pharmaceuticals Corporation | $132.11 | 2021-2023 | |
| Myriad Genetic Laboratories, INC. | $125.50 | 2025 | Myrisk |
| Ethicon US, LLC | $125.40 | 2024 | Echelon; Endopath, Harmonic, Surgicel Nu-Knit |
| Genentech USA, INC. | $54.40 | 2025 | Polivy, Itovebi |
| Baxter Healthcare | $45.81 | 2024-2025 | Tisseel |
| Seagen INC. | $42.49 | 2022-2023 | Tukysa |
| Bayer Healthcare Pharmaceuticals INC. | $41.85 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $31.23 | 2022 | |
| Daiichi Sankyo INC. | $24.08 | 2025 | Enhertu |
| Eisai INC. | $20.88 | 2023 | |
| Amgen INC. | $13.79 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clovis Oncology, INC. | $0.72 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.